ABSTRACT
Purpose: To report a case of reactive infectious mucosal eruption and anterior scleritis in a vaccinated patient following recent recovery from COVID-19. Reactive infectious mucosal eruption (RIME) is a newly recognised complication of SARS COVID-19. Scleritis has also been reported in COVID-19 infections;however, these cases were from early in pandemic prior to vaccine development and were not reported to occur concurrently with RIME. Method(s): This case report illustrates a 25-year old male fully vaccinated against COVID-19 (ComirnatyTM) who presented 2 weeks after recovering from COVID-19 infection with RIME involving the oral mucosal and larynx, and concurrent bilateral anterior necrotising scleritis. Result(s): Consultation was sought from ophthalmology, otolaryngology and dermatology and dental regarding diagnoses and management. The patient's condition rapidly improved following treatment with IV methyprednisolone and oral prednisone taper. Conclusion(s): In cases of diagnostic uncertainty, multidisciplinary collaboration is critical to achieve a timely diagnosis and prevent serious complications.